文献速递儿童神经与发育行为儿童内分泌与遗传代谢

儿童SYNGAP1基因相关癫痫的临床特征与基因分析

[Clinical characteristics and gene analysis of SYNGAP1-related epilepsy in children].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2021-01-01

该研究回顾性分析北京儿童医院13例SYNGAP1基因变异相关癫痫患儿,随访12例。癫痫起病年龄中位2岁,主要发作类型为眼睑肌阵挛伴或不伴失神,丙戊酸钠治疗多有效,所有患儿均存在发育迟缓且以语言落后为著。

要点

  • SYNGAP1相关癫痫起病早,主要发作类型为眼睑肌阵挛伴或不伴失神。
  • 丙戊酸钠治疗多数有效,部分患儿发作仍难以控制。
  • 所有患儿存在发育迟缓,以语言落后为著,多为中度至重度。

核心结论

  • SYNGAP1基因相关儿童癫痫起病年龄较早,发作类型多样,主要发作类型为眼睑肌阵挛伴或不伴失神。
  • 丙戊酸治疗多有效,但部分患者可能为药物难治性癫痫。
  • 患儿存在不同程度发育迟缓,以语言落后为著,多为中度或重度。

研究设计与样本

  • 回顾性收集首都医科大学附属北京儿童医院神经内科2017年3月至2020年10月就诊的13例SYNGAP1基因变异相关癫痫患儿并进行随访。
  • 总结患儿的临床特点、脑电图、头颅影像学、基因结果及治疗情况。

主要发现

  • 13例患儿中随访到12例,末次随访年龄5岁7月龄(3岁1月龄至9岁)。
  • 癫痫发作起病年龄为2岁(4月龄至3岁)。
  • 发作类型包括眼睑肌阵挛伴或不伴失神9例、肌阵挛发作5例、不典型失神4例、可疑失张力发作4例、跌倒发作6例(具体发作类型不详),发作频率每日数次到百余次。
  • 4例表型类似肌阵挛-失张力综合征;10例发作有诱因,包括进食5例、情绪5例、发热3例、声音2例、劳累2例等。
  • 10例患儿脑电图提示9例发作间期广泛性或局灶性痫样放电,监测到不典型失神4例、肌阵挛发作2例和眼睑肌阵挛伴失神发作1例。

关键数值与推荐

  • 12例中9例加用丙戊酸钠均有效(发作减少50%以上)。
  • 5例联用左乙拉西坦,3例有效。
  • 至末次随访3例发作相对控制(6个月至1年1个月),余7例仍有发作(数日1次或每日数次)。
  • 13例均存在发育落后,2例重度、10例中度、1例轻度。
  • 13例患儿携带SYNGAP1基因变异,均为新生变异,包括12个变异位点:移码变异4个、无义变异4个、错义变异2个、剪切位点变异2个。

临床怎么用

  • 对起病早、发作类型多样(尤其眼睑肌阵挛伴或不伴失神)且伴发育迟缓的癫痫患儿,应考虑SYNGAP1基因变异可能。
  • 丙戊酸钠可作为SYNGAP1相关癫痫的治疗选择之一,但需注意部分患儿可能药物难治。
  • 应关注患儿发育情况,尤其是语言能力,并进行相应评估和干预。

局限性

  • 本研究为单中心回顾性研究,样本量较小(13例)。
  • 随访时间有限,末次随访年龄中位5岁7月龄,长期预后尚不明确。
  • 未报告头颅影像学结果及其他抗癫痫药物的详细疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To summarize the clinical characteristics of SYNGAP1-related epilepsy in children. Methods: Data of 13 patients with SYNGAP1 gene variants diagnosed with epilepsy at Department of Neurology, Beijing Children's Hospital were collected retrospectively from March 2017 to October 2020 and the patients were followed up. The clinical features, electroencephalogram(EEG), brain imaging, gene results and treatment were summarized. Results: Twelve patients were followed up successfully among the 13 patients with SYNGAP1 variants. The last follow-up age was 5 years and 7 months (3 years and 1 month to 9 years).The onset age of seizures was 2 years (4 months to 3 years). Seizure types included eyelid myoclonia with or without absence (9 cases), myoclonic seizure (5 cases), atypical absence (4 cases), suspicious atonic seizures(4 cases),unclassified fall attack (6 cases), and the frequency of seizures varied from several times to more than 100 times per day. Four cases had the mimic phenotype of myoclonic astatic epilepsy. The seizures of 10 cases could be triggered by eating (5 cases), emotion (5 cases), fever (3 cases), voice (2 cases), fatigue (2 cases), etc. Electroencephalography (10 cases) showed interictal generalized or focal epileptiform discharges (9 cases), and atypical aphasia (4 cases), myoclonic seizure (2 cases) and eyelid myoclonic seizure (1 case) were monitored. Of the 12 cases, 9 were added with valproate, all of which were effective (the frequency of seizures reduced>50%). Five cases received combined levetiracetam, in 3 the treatments were effective. To last follow-up, 3 cases were seizure free from 6 months to 1 year and 1 month, but the remaining 7 cases still had seizures, one or several times per day. All 13 cases had developmental retardation (speech ability impaired mostly), 2 cases were severe, 10 cases were moderate, 1 case was mild. The SYNGAP1 gene variants of 13 patients were all de novo, including 12 variants. Among them, 4 were frameshift variants, 4 were nonsense variants, 2 were missense variants and 2 were splice site variants. Conclusions: Patients with SYNGAP1-related epilepsy have an early onset age and many seizure types. The main seizure type is eyelid myoclonia with or without absence, and other seizure types include myoclonic seizure, atypical absence, unclassified fall attack, etc. Valproate is effective in most patients, but seizures in some patients might be intractable. Most patients have developmental delay (mainly moderate and severe), speech ability impaired mostly. 目的: 总结SYNGAP1基因相关儿童癫痫的临床特点。 方法: 回顾性收集首都医科大学附属北京儿童医院神经内科2017年3月至2020年10月就诊的13例SYNGAP1基因变异相关癫痫患儿,并进行随访,对其临床特点、脑电图、头颅影像学、基因结果、治疗等进行总结。 结果: 13例患儿(男4例、女9例)随访到12例,末次随访年龄5岁7月龄(3岁1月龄至9岁)。癫痫发作起病年龄为2岁(4月龄至3岁),发作类型包括眼睑肌阵挛伴或不伴失神(9例)、肌阵挛发作(5例)、不典型失神(4例)、可疑失张力发作(4例)、跌倒发作(6例,具体发作类型不详),发作频率每日数次到百余次。4例表型类似肌阵挛-失张力综合征。10例发作有诱因,包括进食(5例)、情绪(5例)、发热(3例)、声音(2例)、劳累(2例)等。10例患儿脑电图提示9例发作间期广泛性或局灶性痫样放电,监测到不典型失神4例、肌阵挛发作2例和眼睑肌阵挛伴失神发作1例。12例中9例加用丙戊酸钠均有效(发作减少50%以上),5例联用左乙拉西坦3例有效,至末次随访3例发作相对控制(6个月至1年1个月),余7例仍有发作(数日1次或每日数次)。13例均存在发育落后(语言落后为著),2例重度,10例中度,1例轻度。13例患儿携带SYNGAP1基因变异,均为新生变异,包括12个变异位点。其中移码变异4个,无义变异4个,错义变异2个,剪切位点变异2个。 结论: SYNGAP1基因相关儿童癫痫起病年龄较早,发作类型多样,主要发作类型为眼睑肌阵挛伴或不伴失神,还可有肌阵挛发作、不典型失神、跌倒发作等。丙戊酸治疗多有效,部分可为药物难治性癫痫。患儿存在不同程度发育迟缓,以语言落后为著。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Tian XJ, Fang F, Ding CH, et al. [Clinical characteristics and gene analysis of SYNGAP1-related epilepsy in children]. Zhonghua Er Ke Za Zhi. 2021. PMID: 34856666. doi:10.3760/cma.j.cn112140-20210430-00369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。